Noeadjuvant chemoradiotherapy with 5-fluorouracil-cisplatin combined with cetuximab in patients with resectable locally advanced
esophageal carcinoma: A prospective phase I/II trial (FFCD-PRODIGE 3)Preliminary phase II results
ANNÉE
2012
AUTEURS
Dahan L, Mariette C, Adenis A, Smith D, d Journo X, Pezet D, Mornex F, Carrère N, Bonnetain F, Seitz JF
CONGRÈS/REVUE
ASCO
LIEN PUBLICATIONS ASSOCIÉES